Skip to main content
OpenTrials

Clinical trial condition

Diphtheria

Explore clinical trials studying Diphtheria. Study availability and eligibility vary by location and protocol.

202 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Diphtheria trial results

Completed

Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults

NCT01323959

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations
  • GSK Investigational Site Derval, France
  • GSK Investigational Site La Chapelle-Basse-Mer, France
  • GSK Investigational Site La Riche, France
  • GSK Investigational Site Nantes, France
View all 15 locations
View Trial Details
Completed

Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.

NCT00871000

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations
  • GSK Investigational Site Genoa, Liguria, Italy
  • GSK Investigational Site Milan, Lombardy, Italy
  • GSK Investigational Site Novara, Piedmont, Italy
  • GSK Investigational Site Cagliari, Sardinia, Italy
View Trial Details
Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults

NCT01738477

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Tempe, Arizona, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Fullerton, California, United States
View all 20 locations
View Trial Details
Completed

Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older

NCT01287949

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
Locations
  • Sanofi Pasteur MSD investigational site Clermont-Ferrand, France
  • Sanofi Pasteur MSD investigational site Lille, France
  • Sanofi Pasteur MSD investigational site Montpellier, France
  • Sanofi Pasteur MSD investigational site Paris, France
View Trial Details
Completed

Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE

NCT01546909

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +18 more
Locations
  • SPMSD Investigational Site 120 Angers, France
  • SPMSD Investigational Site 103 Arras, France
  • SPMSD Investigational Site 155 Asnières, France
  • SPMSD Investigational Site 125 Bersée, France
View all 45 locations
View Trial Details

Related conditions